Renata PLC, a leading pharmaceutical company in Bangladesh, has begun exporting two new products—Sertraline 100mg and Propylthiouracil 50mg—to the UK.

According to a company disclosure posted on the Dhaka Stock Exchange, the products manufactured at Renata’s Gazipur facility will be marketed under its own brand in the UK.

Sertraline, a widely prescribed antidepressant, and Propylthiouracil, used to treat hyperthyroidism, mark the company’s growing focus on chronic care solutions in the UK market.